Clinical Trial Update: UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide [Phase 3]

View source ↗

Summary

Phase 3 trial in multiple myeloma evaluating tandem stem cell transplants with or without bortezomib and thalidomide; the study was terminated and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalomid (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2011-06-30